Dr.
Axel Ullrich
Max-Planck-Institut für Biochemie
Molecular biologist; Company research staff member; Research institution staff member and administrator
Area
Biological Sciences
Specialty
Biochemistry, Biophysics, and Molecular Biology
Elected
2005
International Honorary Member
Leader in molecular medicine and growth factor receptor research. Pioneer in the cloning of insulin gene sequences and discovery of the receptor tyrosine kinase HER2, which led to the development of effective breast cancer therapeutics. Provided insights into the roles of oncogenes and receptor tyrosine kinases in cancer and angiogenesis.
Last Updated